52 articles
Alexander G.G. Turpie
Alexander G.G. Turpie is a Glasgow-trained physician-scientist in thrombosis research, Professor Emeritus of Medicine at McMaster University who led trials of rivaroxaban and fondaparinux and wrote more than 700 publications.
Andrew I. Schafer
Andrew I. Schafer is an American hematologist-oncologist known for research on thrombosis and platelet function, the widely cited 2004 NEJM review "Thrombocytosis," and leadership of hematology departments at Baylor, Penn, and Weill Cornell.
Armand J. Quick
Armand J. Quick (1894–1978) was an American physician and biochemist who developed the prothrombin time blood-clotting test, known as the Quick test, and chaired biochemistry at Marquette.
Armando Tripodi
Armando Tripodi is an Italian scientist in hemostasis and thrombosis at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center in Milan, known for the rebalanced hemostasis concept in cirrhosis.
Arnaud Perrier
Arnaud Perrier, born in 1959, is a Swiss internal medicine researcher at Geneva who established non-invasive D-dimer pathways for diagnosing pulmonary embolism and venous thromboembolism in outpatients.
Campbell W. McMillan
Campbell W. McMillan (1927–2008) was an American pediatric hematologist at UNC Chapel Hill who co-led the first human trial of genetically engineered recombinant factor VIII in 1987.
Darrel W. Stafford
Darrel W. Stafford is a Professor Emeritus of biology at the University of North Carolina at Chapel Hill who identified the gene for vitamin K epoxide reductase.
Deane F. Mosher
Deane F. Mosher is a professor of biomolecular chemistry and Medicine at the University of Wisconsin–Madison whose laboratory studies fibronectin, thrombospondins, and vitronectin in blood plasma and platelets.
Duncan P. Thomas
Duncan P. Thomas is a hematologist and thrombosis researcher known for work on pulmonary embolism, platelet aggregation, and heparin, who taught at Tufts and later worked in England.
Edward G. D. Tuddenham
Edward G. D. Tuddenham is a British haematologist and Emeritus Professor of Haemophilia at University College London, known for cloning factor VIII and hemophilia B gene therapy.
Edwin W. Salzman
Edwin W. Salzman was an American surgeon and Harvard professor who led clinical trials on preventing venous thromboembolism and served 13 years as deputy editor of the New England Journal of Medicine.
Erik Adolf von Willebrand
Erik Adolf von Willebrand (1870–1949) was a Finnish internist who in 1926 described an inherited bleeding disorder among Åland island families, now called von Willebrand disease.
Flora Peyvandi
Flora Peyvandi is an Italian hematologist at the University of Milan who led the SIPPET and HERCULES trials and served as ISTH President from 2022 to 2024.
Frits R. Rosendaal
Frits R. Rosendaal (born 1959) is a Dutch physician-scientist, professor of clinical epidemiology at Leiden University, known for identifying genetic and acquired causes of venous thrombosis.
Gary E. Raskob
Gary E. Raskob is an epidemiologist and clinical researcher in thrombosis medicine who led the Hokusai-VTE Cancer trial and became provost of the University of Oklahoma Health Campus in 2022.
Gian Gastone Neri Serneri
Gian Gastone Neri Serneri (1925–2020) was an Italian physician and professor of internal medicine at Florence whose clinical trials established low-dose heparin for unstable angina.
Glenn F. Pierce
Glenn F. Pierce is an American hematologist and physician-researcher, born with severe hemophilia A and cured in 2008, who helped develop six hemophilia therapies and led Biogen's hemophilia program.
Gordon Lowe
Gordon Lowe, born 1949, is a Scottish physician-scientist who was Professor of Vascular Medicine at Glasgow from 1993 to 2009 and showed that raised clotting factor levels increase thrombosis risk.
Herbert S. Strauss
Herbert S. Strauss was an American physician-scientist in hematology who in the 1960s defined factor VIII inhibitors in hemophilia A and the clinical picture of von Willebrand's disease.
Hidehiko Saito
Hidehiko Saito (齋藤英彦) is a Japanese hematologist, professor emeritus of Nagoya University, known for identifying the Fletcher and Fitzgerald clotting factors and establishing the MEG-01 leukemia cell line.
Ipseeta Menon
Ipseeta Menon, a researcher who focused on fibrinolytic activity, proposed that the kidney and brain contribute plasminogen activator to the circulation in amounts determined by blood flow.
J. Evan Sadler
J. Evan Sadler (1951–2018) was an American hematologist who directed hematology at Washington University in St. Louis and was known for research on von Willebrand factor and ADAMTS13.
Jeffrey I. Weitz
Jeffrey I. Weitz, also known as Jeffrey Weitz, is a Canadian hematologist at McMaster University who studies blood coagulation and led trials of anticoagulant drugs including milvexian.
John Pasi
K. John Pasi is a British hematologist who led the first successful gene therapy program for hemophilia A and is a professor at Queen Mary University of London.
John Suttie
John Suttie, also known as John W. Suttie, was an American biochemist at the University of Wisconsin–Madison who worked out how vitamin K enables blood coagulation.
John W. Weisel
John W. Weisel is a biophysicist and professor of cell and developmental biology at the University of Pennsylvania, known for his 1985 fibrinogen model and work on clot mechanics.
Jos Vermylen
Jos Vermylen (Jozef Vermylen) is a Belgian physician-scientist in hematology, Emeritus Professor of Medicine at the University of Leuven, known for platelet and thromboxane research.
Joseph P. Miletich
Joseph P. Miletich is a physician-scientist in hematology and thrombosis, known for protein C deficiency research, who was a professor at Washington University and later a research executive at Amgen and Merck.
Kenneth G. Mann
Kenneth G. Mann, born Kenneth Gerard Mann, is an American biochemist and hemostasis researcher, professor emeritus at the University of Vermont, known for the prothrombinase complex.
Laszlo Lorand
Laszlo Lorand (1923–2018) was a Hungarian-born American biochemist who co-discovered the blood-clotting protein Factor XIII, formerly called the Laki-Lorand factor, and spent more than 60 years at Northwestern University.